AI assistant
Sending…
Inotiv, Inc. — Director's Dealing 2021
Jan 12, 2021
34595_dirs_2021-01-12_4e520b98-874f-438a-b12e-44f79794f1e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2020-02-20
Reporting Person: Neff R Matthew (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-20 | Common Shares | P | 9458 | $4.60 | Acquired | 31583 | Direct |
Footnotes
F1: The reporting person filed this amendment to correct the amount of securities identified as beneficially owned following the reported transaction.
More from Inotiv, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 10
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19